Serum HER-2/neu conversion to positive at the time of cancer progression in metastatic breast patients treated with letrozole vs. tamoxifen.

被引：0
|
作者：
Lipton, A
Leitzel, K
Ali, SM
Demers, L
Harvey, HA
Chaudri-Ross, HA
Lang, R
Hackl, W
Hamer, P
Carney, W
机构：
[1] Penn State Hershey Med Ctr, Lebanon VA Med Ctr, Hershey, PA USA
[2] Novartis Pharma AG, Basel, Switzerland
[3] Oncogene Sci Bayer Diagnost, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：288S / 288S
页数：1
相关论文
共 50 条
  • [21] Serum EGFr and HER-2/neu predicts poor survival in metastatic breast cancer
    Hamer, P. J.
    Jarosz, D. E.
    Leitzel, K.
    Ali, S. M.
    Demers, L.
    Evans, D. B.
    Chaudri-Ross, H. A.
    Lipton, A.
    Camey, W. P.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A168 - A168
  • [22] HER-2/neu in tissue and serum at time of primary diagnosis of breast cancer
    Dresse, M.
    Mayr, D.
    Heinemann, V.
    Kahlert, S.
    Bauerfeind, I.
    Nagel, D.
    Seidel, D.
    Stieber, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] HER-2/NEU IN TISSUE AND SERUM AT TIME OF PRIMARY DIAGNOSIS OF BREAST CANCER
    Dresse, M.
    Mayr, D.
    Heinemann, V.
    Kahlert, S.
    Bauerfeind, I.
    Nagel, D.
    Seidel, D.
    Stieber, P.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4027 - 4027
  • [24] HER-2/neu expression in primary and metastatic breast cancer
    Elyse E. Lower
    Eleanor Glass
    Robbin Blau
    Stacy Harman
    Breast Cancer Research and Treatment, 2009, 113 : 301 - 306
  • [25] Correlation of serum HER-2/neu extracellular domain levels in metastatic breast cancer with the expression of HER-2/neu in corresponding primary tumors
    Witzel, I.
    Mueller, V.
    Wiczak, W.
    Bubenheim, W.
    Jaenicke, F.
    Thomssen, C.
    EJC SUPPLEMENTS, 2004, 2 (03): : 178 - 178
  • [26] HER-2/neu expression in primary and metastatic breast cancer
    Lower, Elyse E.
    Glass, Eleanor
    Blau, Robbin
    Harman, Stacy
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (02) : 301 - 306
  • [27] Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
    Mokhtari, Maral
    Khosravi, Mohammad Hadi
    MIDDLE EAST JOURNAL OF CANCER, 2021, 12 (04) : 483 - 490
  • [28] Tissue expression and serum levels of HER-2/neu in patients with breast cancer
    Krainer, M
    Brodowicz, T
    Zeillinger, R
    Wiltschke, C
    Scholten, C
    Seifert, M
    Kubista, E
    Zielinski, CC
    ONCOLOGY, 1997, 54 (06) : 475 - 481
  • [29] Tissue expression and serum levels of HER-2/neu in patients with breast cancer
    Brodowicz, T
    Krainer, M
    Zeillinger, R
    Budinsky, AC
    Wiltschke, C
    Zielinski, CC
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 657 - 657
  • [30] Clinical use of the serum marker HER-2/NEU in patients with breast cancer
    Dalu, D.
    Cattaneo, M. T.
    Piazza, E.
    Piva, S.
    Gambaro, A.
    Tosca, N.
    Gabris, A.
    Filipazzi, V
    Esani, G.
    Somma, L.
    Sarnataro, C.
    Zambelli, S.
    Damiani, E.
    ANNALS OF ONCOLOGY, 2007, 18 : 45 - 45
12345